Could cause temporary or reversible harm; serious harm is unlikely.
Subpotent Drug
| Brand name | METHYLERGONOVINE MALEATE |
| Generic name | METHYLERGONOVINE MALEATE |
| Active ingredient(s) | METHYLERGONOVINE MALEATE |
| Distributed by / for | MAJOR PHARMACEUTICALS, Indianapolis, in 46268 |
| NDC | 0904-7282-10 |
| Full product label | Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister Label: Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268, NDC 0904-7282-10. |
| Recalling firm | The Harvard Drug Group LLC |
| Distribution | U.S. Nationwide. |
| Quantity | 790 Cartons. |
| Recall initiated | 2026-06-16 |
| Report date | 2026-07-01 |
| Recall completed | — |
| Recall number | D-0609-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Dublin OH United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗